BRAINSTORM CELL THERAPEUTICS

CUSIP: 10501E201 Class: COM NEW

CHARLES SCHWAB INVESTMENT MANAGEMENT INC's Holding History (CIK: 0000884546)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 11,287 Value ($000) $2 Avg Close Range
Q2 2023
Shares 11,287 Value ($000) $23 Avg Close Range
Q1 2023
Shares 11,287 Value ($000) $37 Avg Close Range
Q4 2022
Shares 11,287 Value ($000) $19 Avg Close Range
Q3 2022
Shares 11,287 Value ($000) $50 Avg Close Range
Q2 2022
Shares 11,287 Value ($000) $32 Avg Close Range
Q1 2022
Shares 11,287 Value ($000) $38 Avg Close Range
Q4 2021
Shares 11,287 Value ($000) $46 Avg Close Range
Q3 2021
Shares 11,287 Value ($000) $38 Avg Close Range
Q2 2021
Shares 11,287 Value ($000) $43 Avg Close Range
Q1 2021
Shares 78,115 Value ($000) $300 Avg Close Range
Q4 2020
Shares 65,240 Value ($000) $296 Avg Close Range
Q3 2020
Shares 70,593 Value ($000) $1,195 Avg Close Range
Q2 2020
Shares 68,781 Value ($000) $772 Avg Close Range
Q1 2020
Shares 11,287 Value ($000) $53 Avg Close Range
Q4 2019
Shares 11,287 Value ($000) $49 Avg Close Range
Q3 2019
Shares 11,287 Value ($000) $45 Avg Close Range
Q2 2019
Shares 11,287 Value ($000) $45 Avg Close Range
Q1 2019
Shares 11,287 Value ($000) $49 Avg Close Range